Cero Therapeutics (CERO) holder Isaiah Tibbs reports 4.63% ownership stake
Rhea-AI Filing Summary
Cero Therapeutics Holdings, Inc. reported an updated ownership disclosure from shareholder Isaiah Tibbs. Tibbs beneficially owns 2,089,000 shares of Cero Therapeutics common stock, representing 4.63% of the class, based on 45,112,406 shares outstanding as of the second quarter. All of these shares are reported with sole voting and sole dispositive power, with no shared voting or dispositive authority. The filing notes that the position now reflects ownership of 5 percent or less of the company’s common stock.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 2,089,000 shares
Ownership percentage: 4.63%
Shares outstanding: 45,112,406 shares
+2 more
5 metrics
Shares beneficially owned
2,089,000 shares
Common stock beneficially owned by Isaiah Tibbs
Ownership percentage
4.63%
Percent of Cero Therapeutics common stock owned by Isaiah Tibbs
Shares outstanding
45,112,406 shares
Common shares outstanding as of Q2, basis for ownership percentage
Sole voting power
2,089,000 shares
Shares over which Tibbs has sole power to vote or direct the vote
Sole dispositive power
2,089,000 shares
Shares over which Tibbs has sole power to dispose or direct disposition
Key Terms
beneficially owned, sole voting power, sole dispositive power, percent of class
4 terms
beneficially owned financial
"Ownership (a) | Amount beneficially owned: 2,089,000"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power financial
"Sole power to vote or to direct the vote: 2,089,000"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"Sole power to dispose or to direct the disposition of: 2,089,000"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
percent of class financial
"Percent of class: 4.63 - based on 45,112,406 shares"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
FAQ
What ownership stake in CERO does Isaiah Tibbs report in this Schedule 13G/A?
Isaiah Tibbs reports beneficial ownership of 2,089,000 shares of Cero Therapeutics Holdings, Inc. (CERO) common stock, representing 4.63% of the outstanding class, based on 45,112,406 shares outstanding as of the second quarter.
What percentage of CERO’s common stock is owned by Isaiah Tibbs?
Isaiah Tibbs reports beneficially owning 4.63% of Cero Therapeutics Holdings, Inc. (CERO) common stock. This percentage is calculated based on 45,112,406 shares of common stock outstanding as of the company’s second quarter.
Does the filing indicate Isaiah Tibbs owns more than 5% of CERO?
No. The filing states that Isaiah Tibbs owns 4.63% of Cero Therapeutics Holdings, Inc. (CERO) common stock and specifically notes ownership of 5 percent or less of the class, reflecting a sub‑5% position.
AI-generated analysis. How Rhea-AI works. Not financial advice.